The Economic Burden of Insomnia: Direct and Indirect Costs for Individuals with Insomnia Syndrome, Insomnia Symptoms, and Good Sleepers
Open Access
- 1 January 2009
- journal article
- Published by Oxford University Press (OUP) in Sleep
- Vol. 32 (1), 55-64
- https://doi.org/10.5665/sleep/32.1.55
Abstract
Insomnia is a highly prevalent problem that is associated with increased use of health care services and products, as well as functional impairments. This study estimated from a societal perspective the direct and indirect costs of insomnia. A randomly selected sample of 948 adults (mean age = 43.7 years old; 60% female) from the province of Québec, Canada completed questionnaires on sleep, health, use of health-care services and products, accidents, work absences, and reduced productivity. Data were also obtained from the Quebec government administered health insurance board regarding consultations and hospitalizations. Participants were categorized as having insomnia syndrome, insomnia symptoms or as being good sleepers using a standard algorithm. Frequencies of target cost variables were obtained and multiplied by unit costs to generate estimates of total costs for the adult population of the province of Quebec. The total annual cost of insomnia in the province of Quebec was estimated at $6.6 billion (Cdn$). This includes direct costs associated with insomnia-motivated health-care consultations ($191.2 million) and transportation for these consultations ($36.6 million), prescription medications ($16.5 million), over the-counter products ($1.8 million) and alcohol used as a sleep aid ($339.8 million). Annual indirect costs associated with insomnia-related absenteeism were estimated at $970.6 million, with insomnia-related productivity losses estimated at $5.0 billion. The average annual per-person costs (direct and indirect combined) were $5,010 for individuals with insomnia syndrome, $1,431 for individuals presenting with symptoms, and $421 for good sleepers. This study suggests that the economic burden of insomnia is very high, with the largest proportion of all expenses (76%) attributable to insomnia-related work absences and reduced productivity. As the economic burden of untreated insomnia is much higher than that of treating insomnia, future clinical trials should evaluate the cost-benefits, cost-utility, and cost-effectiveness of insomnia therapies. Daley M; Morin CM; LeBlanc M; Grégoire JP; Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. SLEEP 2009;32(1):55-64.Keywords
This publication has 24 references indexed in Scilit:
- Epidemiology of insomnia: Prevalence, self-help treatments, consultations, and determinants of help-seeking behaviorsSleep Medicine, 2006
- The Economic Cost of Sleep DisordersSleep, 2006
- Professional Correlates of InsomniaSleep, 2006
- Validation of the Insomnia Severity Index as an outcome measure for insomnia researchSleep Medicine, 2001
- Effects of chronic insomnia and use of benzodiazepines on daytimeperformance in older adultsThe Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 2000
- The direct costs of insomnia in France.1999
- Prevalence, burden, and treatment of insomnia in primary careAmerican Journal of Psychiatry, 1997
- Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.1996
- Economic effects of insomnia.1994
- Good and Poor Sleepers Differ in Navy PerformanceMilitary Medicine, 1983